LATEST ISSUE
January/February 2023
With the promise of more rare disease treatments on the horizon (particularly genetic treatments for hemophilia and sickle cell disease, which promise to be “one and done” therapies), their much higher per patient cost will create market access and other challenges to payers, providers, and patients.
VOL. 8, NO. 5
September/October 2022
Valuing the Health of Children: Understanding What Drives Differences in Health Preferences for Children Versus Adults
VOL. 8, NO. S1
September 2022
A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology
VOL. 7, NO. 6
November/December 2021
Finding the Best and Brightest: Getting a Leg Up on the Race for Talent
Vol. 7, No. S2
September 2021
Patients Versus Process: The Data and the Drivers Behind Patient-Centered Outcomes
VOL. 7, NO. 2 S1
March 2021
Valuing Future Alzheimer's Disease Treatments: The Need for a Holistic Approach
VOL. 6, NO. 6
November/December 2020
Challenges in Precision Medicine: Aiming to Align Data, Value, and Costs
